John Valliant
Founder at FUSN PHAR
Net worth: 7 M $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Damian Lamb | M | 52 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Pablo Cagnoni | M | 60 | 5 years | |
Amanda Cray | F | - | - | |
Christopher Kelly | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Gay Yuyitung | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Bruno Paquin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Steven Gannon | M | 62 | 4 years | |
Jean-Claude Provost | M | 60 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Annick Van den Abbeele | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Eric Burak | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 12 years |
Karen Gulenchyn | F | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Peter Pattison | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Philina Lee | M | 47 | 3 years | |
Donald Bergstrom | M | 52 | 3 years | |
Bettina Hamelin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Sheila Singh | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Lana Janes | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Barbara Duncan | F | 59 | 4 years | |
Anton Knezovic | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
David Huctwith | M | - |
McMaster University
| - |
Arjun Kumar | M | - |
McMaster University
| - |
Martin Kolb | M | - |
McMaster University
| - |
Constantinos Economou | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Michael Ferencich | M | - |
McMaster University
| - |
Barry Nicol | M | - |
McMaster University
| - |
Judith Shedden | F | - |
McMaster University
| - |
Jeanne Tan | F | - |
McMaster University
| - |
Chris Sinding | M | - |
McMaster University
| - |
Arlene Dosen | F | - |
McMaster University
| - |
Jerry Hurley | M | - |
McMaster University
| - |
Pamela Swett | F | - |
McMaster University
| - |
Karen Mossaman | F | - |
McMaster University
| - |
Marc Letendre | M | - |
McMaster University
| - |
Fiona McNeill | F | - |
McMaster University
| - |
Sara Bannerman | F | - |
McMaster University
| - |
Juliet Daniel | F | - |
McMaster University
| - |
Spencer Pope | M | - |
McMaster University
| - |
Judy West-Mays | F | - |
McMaster University
| - |
Sandeep Raha | M | - |
McMaster University
| - |
Dean Mountain | M | - |
McMaster University
| - |
Christina Bryce | F | - |
McMaster University
| - |
Stephanie Baschiera | F | - |
McMaster University
| - |
Khaled Hassanein | M | - |
McMaster University
| - |
Sonny Kohli | M | - |
McMaster University
| 14 years |
Michael Verbora | M | - |
McMaster University
| 6 years |
Marion B. Lyver | M | - |
McMaster University
| - |
James Macpherson | M | - |
McMaster University
| - |
Paul D. Campbell | M | 76 |
McMaster University
| - |
Ronald Loucks | M | - |
McMaster University
| - |
John Bienenstock | M | 87 |
McMaster University
| - |
Robert G. Cooper | M | - |
McMaster University
| - |
James Paul | M | - |
McMaster University
| - |
Emõke J. E. Szathmáry | M | 81 |
McMaster University
| - |
James B. Mahony | M | - |
McMaster University
| - |
Richard Rossman | M | - |
McMaster University
| - |
John Thornback | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Kevin P. D. Smith | M | 61 |
McMaster University
| - |
Rocco Taglioni | M | - |
McMaster University
| - |
Jim A. Wright | M | - |
McMaster University
| 14 years |
H. Barber | M | - |
McMaster University
| - |
Fraser Reeve Berrill | M | 75 |
McMaster University
| - |
Lynton R. Wilson | M | 84 |
McMaster University
| - |
Mary Maher | F | 63 |
McMaster University
| - |
Peter Horsewood | M | - |
McMaster University
| - |
Natalia K. Nikolova | M | - |
McMaster University
| 25 years |
Woo-Young Kim | M | - |
McMaster University
| 13 years |
Joseph Gabriele | M | - |
McMaster University
| - |
John Manley | M | 74 |
McMaster University
| - |
Jeffrey Weitz | M | - |
McMaster University
| - |
Michael T. Newhouse | M | - |
McMaster University
| - |
John Wallace | M | 67 |
McMaster University
| - |
John C. Luxat | M | - |
McMaster University
| - |
Connie A. Stefankiewicz | F | - |
McMaster University
| - |
Grant B. Walsh | M | 75 |
McMaster University
| - |
Gary Kain | M | - |
McMaster University
| - |
Marc Kealey | M | - |
McMaster University
| - |
Paul Dixon Allison | M | - |
McMaster University
| - |
Yaser M. Haddara | M | - |
McMaster University
| - |
Emechete Onuoha | M | - |
McMaster University
| - |
Roger Couldrey | M | - |
McMaster University
| - |
Mark Larché | M | - |
McMaster University
| - |
S. R. Rafael Jose Faucher | M | - |
McMaster University
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Cindy Ward | F | - |
McMaster University
| 21 years |
Lisa Walter | M | - |
McMaster University
| 10 years |
Mark Mihaljevic | M | - |
McMaster University
| 3 years |
Chau Khuong | M | 48 | 4 years | |
Aidan Giangregorio | M | - |
McMaster University
| 6 years |
Ryan Mitchell | M | - |
McMaster University
| 10 years |
Lynn Wick | F | - | 4 years | |
Michael Li | M | - |
McMaster University
| 7 years |
Paul Easterbrook | M | - |
McMaster University
| 6 years |
Rami Rahal | M | - |
McMaster University
| 4 years |
T. Buckley | M | 48 |
McMaster University
| 6 years |
Ryan T. Goulding | M | - |
McMaster University
| 7 years |
Todd D'Amico | M | - |
McMaster University
| 6 years |
Shah Altamash Khan | M | - |
McMaster University
| 7 years |
Kris Somers | M | - |
McMaster University
| 5 years |
Colum Bastable | M | 77 |
McMaster University
| - |
David Fidler | M | - |
McMaster University
| 2 years |
Jeff Pootoolal | M | - |
McMaster University
| 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Valliant
- Personal Network